- A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma
- A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)
- A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
- Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC
- Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma
- Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer
- Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
- Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
- Cabozantinib S-Malate, Crizotinib, Savolitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer
- Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
- Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer
- Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
- Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602)
- RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe
- Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC
- Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer
- Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial
- Testing of Bevacizumab, Erlotinib, and Atezolizumab for Advanced-Stage Kidney Cancer
- Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, the RadiCaL Study
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery
Clinical Trials
- 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
- Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
- Exendin PET/CT for Imaging of Paragangliomas
- GA-68 DOTA-TOC of Somatostatin Positive Malignancies
- Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors
- Prognostic’s Factors of Head and Neck Paragangliomas Evolution
- Characteristics of Nondystrophic Myotonias
- Mexiletine and Non Dystrophic Myotonias
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
- Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
- Using MRI in Patients With Non-dystrophic Myotonia to Access Muscle Contractility
- “Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis”
- A Neuroprosthesis for Prolonged Standing After SCI Using Multi-Contact Peripheral Nerve Electrodes
- A Neuroprosthesis for Seated Posture and Balance
- A Pilot Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
- A Study Testing Safety and Tolerance of the ReWalk Exoskeleton Suit
- Adjusting Wheelchair Set-Up to Minimize Shoulder Joint Forces During Propulsion
- Assessment of Vasomotion of People With Spinal Cord Injury
- Body Composition Assessment in Spinal Cord Injury
- Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient
- Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis
- Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury
- Evaluation of a Hybrid Prototype Strategy (Electrostimulation of Lower Limb Muscles Associated With Voluntary Strengthening of the Upper Limbs) in Reconditioning to Effort in Patients With Chronic Paraplegia.
- Evaluation of a Power Assistance Device for Wheelchair-DUO
- Evaluation of an Advanced Lower Extremity Neuroprostheses
- Evaluation of Safety and Performance of the Atalante System With Patients With Lower Limb Paralysis
- Exercise to Reduce Obesity in Spinal Cord Injury
- ExoAtlet II For SCI Patients
- Exoskeletal-assisted Walking to Improve Mobility, Bowel Function and Cardio-Metabolic Profiles in Persons With SCI
- Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury
- Functional Electrical Stimulation Cycling in SCI
- Functional Electrical Stimulation With Rowing as Exercise After Spinal Cord Injury
- Gait Training for Individuals With Paraplegia Using the H-MEX Exoskeleton
- High-intensity Interval Training and Mixed Meal Responses in Persons With Spinal Cord Injury
- High-intensity Interval Training for Cardiometabolic Health in Persons With Spinal Cord Injury
- Interactive Telehealth for Wheelchair Users
- Medico-economical Impact of the Brindley Neurosurgical Technique in France
- Multimodal Exercises to Improve Leg Function After Spinal Cord Injury
- Natural History of Shoulder Pathology in Manual Wheelchair Users
- Pressure Ulcer Formation Prevention in Paraplegics Using Computer and Sensory Substitution Via the Tongue.
- Quantification of the Pressure Threshold Related to Tissue Injury in Bedriden Paraplegics
- Retraining Walking After Spinal Cord Injury
- Robotically Assisted Treadmill Training in Spinal Cord Injury (SCI)
- Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO)
- Short-Term Transcutaneous or Epidural Spinal Stimulation for Enabling Motor Function in Humans With SCI
- Spinal Cord Injury Exercise and Nutrition Conceptual Engagement
- Spinal Cord Injury Leg Rehabilitation
- Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study
- Study of the Impact of the Use of a Corset on the Respiratory Function of Patients With Spinal Cord Injury
- The Feasibility and Effects of Low-load Blood-flow Restricted Exercise Following Spinal Cord Injury
- The ReWalk Exoskeletal Walking System for Persons With Paraplegia
- The Safety of ahSC in Chronic SCI With Rehabilitation
- Training With Brain-machine Interfaces, Visuo-tactile Feedback and Assisted Locomotion for Patients With Chronic Complete Paraplegia
- Ultrasonographic Measurements of the Achilles Tendon and Talar Condylar Cartilage Thickness in Paraplegia Patients.
- An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
- European Multicentric Study on Parathyroid Carcinoma
- Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
- Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
- Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior
- Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
- Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
- A Long Term Safety Study of BCX9930 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH
- A Long-term Treatment Study of ACH-0144471 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH
- A Phase 3, Open-Label Study of ALXN1210 in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- A Phase I Study to Assess the Safety APL-2 as an Add-On to Standard of Care in Subjects With PNH
- A Phase III Study Evaluating The Efficacy And Safety Of Crovalimab Versus Eculizumab In Adult And Adolescent Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors.
- A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC “GENERIUM”, Russian Federation)
- A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH
- A Study Evaluating The Efficacy And Safety Of Crovalimab Versus Eculizumab In Adult And Adolescent Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors.
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibition
- A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- A Study of Single-dose MY008211A in Healthy Adults
- A Study to Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haemoglobinuria
- A Study to Evaluate the Efficacy and Safety of APL-2 in Patients With PNH
- A Study to Examine the Long-term Safety, Tolerability, and Effectiveness of Pozelimab and Cemdisiran Combination Therapy in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria
- A Treatment Study of ACH-0144471 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- A Treatment Study of ACH-0144471 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With Inadequate Response to Eculizumab
- ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab
- BCX9930 for the Treatment of PNH in Subjects Not Receiving Other Complement Inhibitor Therapy
- BCX9930 for Treatment of PNH in Subjects With Inadequate Response to C5 Inhibitor Therapy
- Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria
- Compassionate Use of Pozelimab
- Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)
- Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
- Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)
- E07-001: Safety and Efficacy Extension Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients
- Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH
- Efficacy and Safety of the Combination of Pozelimab and Cemdisiran Versus Continued Eculizumab or Ravulizumab Treatment in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria
- Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Study, Assessing Multiple LNP023 Doses in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria
- Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
- Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical Study
- First-in-Human Study of BCX9930 in Healthy Volunteers and Patients With PNH
- Global PNH Patient Registry
- Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies
- Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Long-term Safety of BCX9930 in Subjects With Paroxysmal Nocturnal Hemoglobinuria
- Open-label, Multiple Ascending Dose Study of Ravulizumab (ALXN1210) in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
- Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study
- Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
- Pegcetacoplan Early Access Program for PNH
- Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients
- Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab
- Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. APL-2 in PNH Subjects
- Pozelimab and Cemdisiran Combination Therapy in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Switch From Eculizumab Therapy
- Pozelimab and Cemdisiran Combination Treatment in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Received Pozelimab Monotherapy
- Proof of Concept Study of ACH-0145228 in Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria®
- Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab
- Ravulizumab Subcutaneous (SC) Versus Ravulizumab Intravenous (IV) in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab
- Ravulizumab-Controlled Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Complement Inhibitor Treatment-Naive or Have Not Recently Received Complement Inhibitor Therapy
- Real Life Use of Ravulizumab in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
- REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate Its Long Term Safety, Efficacy and Tolerability.
- rVA576 (Coversin) Long Term Safety and Efficacy Surveillance Study
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)
- Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients
- Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH
- Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
- Study of ARO-C3 in Adult Healthy Volunteers and Patients With Paroxysmal Nocturnal Hemoglobinuria and Complement-Mediated Renal Disease
- Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
- Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment
- Study of Global Coagulation Tests in Patients With Paroxysmal Nocturnal Haemoglobinuria
- Study of NM8074 in Adult Soliris-Treated PNH Patients
- Study of NM8074 in Adult Treatment-Naive PNH Patients
- Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Study to Evaluate the Efficacy and Safety of APL-2 in Patients With PNH
- Study to Evaluate the Efficacy and Safety of REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria
- This is a Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.
- To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104
- To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104
- Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria
- Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576
- Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
- Unrelated And Partially Matched Related Donor PSCT w/ TCR αβ Depletion for Patients With BMF
- Unrelated Donor Stem Cell Transplantation
- A Danish Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients With Coronary Artery Disease Resuscitated From Ventricular Fibrillation Who Receive Complete Revascularization
- A Feasibility Study on Prediction of an ICD Shock by ICD-derived Data
- A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic
- Ability of Home Monitoring® to Detect and Manage the Inappropriate Diagnoses in Implantable Cardioverter Defibrillators.
- ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest
- Acute Feasibility Investigation of a New S-ICD Electrode
- ADVANCE CRT – D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy
- ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy
- Advanced Reperfusion Strategies for Refractory Cardiac Arrest
- AED Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named “One Shock Per Minute”
- Antiarrhythmic Effects of N-3 Fatty Acids
- Antiarrhythmics Versus Implantable Defibrillators (AVID)
- Arrhythmia Genetics in the NEtherlandS
- Arrhythmias in Post-Myocardial Infarction Patients
- Austrian Wearable Cardioverter Defibrillator Registry
- Automatic External Defibrillation Monitoring in Cardiac Arrest
- Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring
- Beta-Blocker Heart Attack Trial (BHAT)
- Better Mechanistic Understanding of and Risk Stratification for Ventricular Tachyarrhythmias Through ECGI
- Canadian Registry of ICD Implant Testing Procedures
- Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
- Cardiac Rehab Retrospective Review (CR3)
- Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
- Cardiopulmonary Resuscitation Performance of Professional Rescuers With a New Defibrillation Algorithm
- Circulating Biomarkers and Ventricular Tachyarrhythmia
- Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device
- CONNECT Study – Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision
- Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response
- DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study
- DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)
- Defining the Electrocardiographic Effect of Propofol on the Ajmaline Provocation Drug Challenge: A Prospective Trial
- Development of CIRC Technologies
- DF4 Connector System Post-Approval Study
- DF4 Master Study (Safety and Efficacy Study)
- DIagnostics, Fatty Acids and Vitamin D in SCA
- DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.
- Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS
- DOuble SEquential External Defibrillation for Refractory VF
- DOuble SEquential External Defibrillation for Refractory VF Pilot Study
- Effect of Right Ventricular Lead Position on Defibrillation Threshold
- Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
- Electrophysiological Effects of Late PCI After MI
- Emotional Regulation in Patients With Implanted Automatic Defibrillator
- Epinephrine Dose: Optimal Versus Standard Evaluation Trial
- European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)
- Evaluation of Depolarization and Repolarisation Activity During Cardiac Arrhythmia Using a Novel Monophasic Action Potential Catheter
- Evaluation of SC-V Versus Conventional CPR
- Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.
- Evaluation of the iD‐SystemTM, One‐Handed Disposable Internal Defibrillation System.
- Extracorporeal Membrane Oxygenation Effect in Prolonged Cardiopulmonary Resuscitation
- Failure of Chronically Implanted Defibrillator Leads -Incidence and Management
- Fatty Acid Antiarrhythmia Trial (FAAT)
- Feature Assessment Study for Indications Based Programming
- First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data
- Further Acute Research of a Subcutaneous Implantable Defibrillator (S-ICD) System
- GANGlion Stellate Block for Treatment of Electric storRm (GANGSTER Trial)
- Gut Microbiome and Ventricular Arrhythmias
- High Low Biphasic Energy Defibrillation (HiLoBED)
- Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients
- Implantable Cardioverter Defibrillator (ICD) Support Groups and Veterans
- Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
- Influence of Mild Therapeutic Hypothermia on Leukocyte Count
- INSIGHTS ICD Registry
- INSURE: INcidence Free SUrvival Before and After Implantable Cardioverter Defibrillator (ICD) Replacement
- International Electrical Storm Registry
- Investigation of Cognitive Function Before and After Induced Ventricular Fibrillation in Electrophysiological (EP) Study
- Italian Registry On Multipoint Left Ventricular Pacing
- Leader – Evaluation of Endotak Reliance
- Left Ventricular Capture Management Study
- LifeVest Post-CABG Registry
- Linkage Study of Long QT Syndrome In An Amish Kindred
- MAVRIC VR ICD Registry
- Medications and the Risk of Sudden Cardiac Death
- Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)
- Noninvasive Electrocardiographic Imaging for Individuals at Risk for Apparently Idiopathic Ventricular Fibrillation.
- Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Cardiopulmonary Resuscitation
- OMNI Study–Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
- OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator
- Out-of Hospital Resuscitation Study
- Parasternal Access for Substernal Shocks and Pacing With an acUtely Placed Less-invasive Lead for EV-ICD (PASS PULL EV-ICD) Study
- Pediatric Lead Extractability and Survival Evaluation (PLEASE)
- Physicians in Training and Critical Care Nurses Performance in Medical Code Events: Effect of Simulation-Based Training
- Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection
- Pre-hospital ECMO in Advanced Resuscitation in Patients With Refractory Cardiac Arrest. ( SUB30 )
- PREVENTION-ACHD Risk Score
- Prognostic Significance of T Wave Alternans
- Prognostic Value of Ventricular Fibrillation Spectral Analysis in Sudden Cardiac Death
- Public Access Defibrillation (PAD) Community Trial
- Real Time Amplitude Spectrum Area to Guide Defibrillation
- Recognizing Ventricular Fibrillation From an Area of a Mobile Phone
- Registry of Device Implantation
- Registry of Malignant Arrhythmias and Sudden Cardiac Death – Influence of Diagnostics and Interventions
- Remote Follow-up of Patients Receiving Implantable Cardioverter Defibrillator for Prophylactic Therapy
- Risk Stratification of VT / VF After Myocardial Infarction Based on Cardiac MRI 2
- Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation
- Safety and Efficacy Study of RENEWAL 4 AVT
- Safety and Performance Study of the RELIANCE 4-Front Passive Fixation Lead
- SAFEty of Two Strategies of ICD Management at Implantation
- SD01 Master Study (Safety and Efficacy Study)
- SD01 Registry (SD01 ICD Lead)
- Sensing and Defibrillation With a Commercially Available ICD Coupled With a Parasternal Extravascular Lead (SECURE EV) Study
- Septal – Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead
- Septal Positioning of Ventricular Implanted Cardioverter Defibrillator (ICD) Leads
- Shockless Implant Evaluation
- SmartCPR Trial: An Analysis of a Waveform-Based Automated External Defibrillation (AED) Algorithm on Survival From Out-of-Hospital Ventricular Fibrillation
- Study of the Wearable Defibrillator in Heart-Failure Patients
- Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study
- The Leiden Nonischemic Cardiomyopathy Study
- The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock
- The Use of Mobile Phones in Out of Hospital Cardiac Arrest to Increase Bystander CPR
- To Determine Optimal Time for Delivering Electrical Shocks to Cardiac Arrest Patients
- Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
- Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
- Unpinning Termination Therapy for VT/VF
- Unpinning Termination Therapy for VT/VF (US)
- Utility and Procedural Feasibility of REBOA Operationalized for Non-Trauma Application (UP-FRONT)
- Vektor vMap™ Clinical Validation Study
- Ventricular Fibrillation Following Out-of-hospital Cardiac Arrest
- VERRARI – “Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?”
- Vest Prevention of Early Sudden Death Trial and VEST Registry
- A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation
- A NEW SCORING SYSTEM FOR PREDICTION OF PDA
- Addition of Acetaminophen in Standard PDA Management
- Aminoglycosides and Duct
- AMPLATZER Duct Occluder II Additional Sizes
- AMPLATZER Duct Occluder II Clinical Study
- Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance
- An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants
- Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
- Canadian National PDA Treatment Study
- Clinical Profile of Neonates Having Patent Ductus Arteriosus
- Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis
- Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants
- Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder
- Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
- Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at
- Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
- Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
- Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
- Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)
- Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
- Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
- Early Treatment Versus Expectative Management of PDA in Preterm Infants
- Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
- Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
- Echocardiography-guided Percutaneous Patent Ductus Arteriosus Closure
- Effect of PDA Closure on the Left Ventricular Remodeling
- Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants
- Evaluation of the Brain and Renal Regional Oxygenation Using NIRS in Preterm Infants
- Feasibility, Efficacy and Safety of IBS ® for Implantaiton in the PDA in Duct-dependent Cyanotic CHD
- Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants
- Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants
- Hemodynamic Responses to Cardio-respiratory Events in Preterm Infants
- Hyperion™ International Registry Trial
- Ibuprofen and Renal Function in Premature Infants
- Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
- Impact of Maternal-infant Therapeutics on Safety, Mortality, and Disability
- Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
- International Experience in Timing And Choices for Ductal Closure in Patent Ductus Arteriosus:INTERPDA Trial
- IV Acetaminophen and Patent Ductus Arteriosus
- Lifetech CeraFlex™ Post-Market Surveillance Study
- Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus
- Long Term Results of 450 Percutaneous Closures of PDA in a Single Center
- Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
- NIRS in PDA VLBW Infants
- Nit-Occlud PDA Post-Approval Study
- Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
- Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.
- Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
- Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial
- Paracetamol (Acetaminophen) for Closure of PDA in Preterm Infants
- Paracetamol and Patent Ductus Arteriosus (PDA)
- Paracetamol Versus Ibuprofen for PDA Closure
- Patent Ductus Arteriosus and Splanchnic Oxygenation at First Feed
- Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates
- PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects
- Pocket Echocardiography System (PES) for Detection of PDA in Neonates
- Population Pharmacokinetics and Dosage Individualization of Paracetamol and Ibuprofen in Children With PDA
- Preliminary Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low-weight Infants
- Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
- Radiation-Free Heart Catheterization Using MRI
- Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus
- Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)
- Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
- Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)
- Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants
- The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the Extremely Low Birth Weight Neonatal Population.
- The Impact of Platelet Functions on Spontaneous Ductal Closure in Preterm Infants
- The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
- The Preterm Infants’ Paracetamol Study
- The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Labour at Term
- The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Preterm Birth
- The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants
- Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
- Treating the Resistant Patent Ductus Arteriosus (PDA)
- Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications
- Chest Wall Motion Analysis in Disease
- Dynamic Compression Brace for Pectus Carinatum
- Effects of Exercise Therapy on Pectus Carinatum
- Effects of Exercise Therapy on Pectus Excavatum
- Health-related Quality of Life in Patients Undergoing Surgery for Pectus Carinatum
- Impact of Risser Stage on Pressure of Correction in Pectus Carinatum
- Impact of Surgical Treatments of Thoracic Deformation on Cardiopulmonary Functions
- Physiological Assessments During Non Operative Treatment on the Chest Wall Deformities
- Prognosis Factors for the Treatment of Pectus Carinatum With a Dynamic Compression System
- Psychological Assessment of Patients With Chest Wall Deformities
- Validity and Reliability of the Turkish Version of the Pectus Carinatum Body Image Quality of Life Questionnaire for Patients With Pectus Carinatum
- Validity and Reliability of the Turkish Version of the Pectus Carinatum Evaluation Questionnaire for Patients With Pectus Carinatum